Identification of FGF21-Inducing Rare Sugars That Reduce Sugar Appetite in Male BL/6 Mice

What the paper shows

Rare sugars are not just sweet substitutes. New work in mouse models shows they talk to a liver hormone called FGF21, and that conversation changes sugar-seeking behavior. The study, published in Physiological Reports (DOI: 10.14814/phy2.70618), identifies D-allulose, D-tagatose, and D-sorbitol as potent FGF21 inducers in mouse primary hepatocytes.

Background

FGF21 is a liver-derived hormone that helps control energy balance. It also acts on the brain to reduce sugar appetite. When you eat sugar, the liver releases FGF21. That signal tells the brain "enough sugar." The researchers wanted to know if rare sugars could trigger this same pathway.

What the study did

The team screened rare sugars in mouse primary hepatocytes. They looked for compounds that raised FGF21. Three did. Then they tested the sugars in live male BL/6 mice. In one set of experiments, they gave the rare sugars by intragastric gavage before offering a sucrose solution. In another, they mixed the rare sugars directly into the sucrose solution.

The behavioral readout was simple. How much sucrose solution did the mice drink? Did they still prefer it when given a choice?

Key findings

The gavage results were clear. All three rare sugars reduced sugar intake. The mixing test added another layer. When the rare sugars were blended with sucrose, total intake dropped, and preference for the sweet solution fell too.

D-allulose stood out. It improved palatability while suppressing appetite. That is a hard balance to hit. Most ingredients either taste good or reduce intake, not both. Here, the mice found the solution palatable, but they stopped drinking sooner. The study describes that as prolonged satiety. The net effect was a lower total intake of the sucrose-containing solution.

Sugar	FGF21 induction in hepatocytes	Effect after intragastric gavage	Effect when mixed with sucrose
D-Allulose	Potent	Reduces sugar intake	Reduces total intake and preference; improves palatability, prolongs satiety
D-Tagatose	Potent	Reduces sugar intake	Reduces total intake and preference
D-Sorbitol	Potent	Reduces sugar intake	Reduces total intake and preference

These compounds deliver sweetness and FGF21 signaling in forms that are metabolized differently from sucrose. That combination is rare in the sweetener world.

What it means for manufacturers

Formulators can stop thinking of D-allulose as a one-for-one sucrose replacer. It is a signaling molecule. If the effect holds in humans, products made with allulose could help people moderate sugar intake, not just because the product has fewer calories, but because the ingredient likely changes appetite at the physiological level.

The mixing data matter too. You do not have to remove all sucrose from a formulation. The paper shows that blending a FGF21-inducing rare sugar with sucrose reduces how much of the total solution mice drink and prefer. That opens a practical door for sugar-reduction strategies that keep some sugar for taste and use allulose as a control lever.

D-tagatose and D-sorbitol deserve attention as well. Both are potent FGF21 inducers. For B2B buyers, that means more than one tool in the kit. Price, supply, and regulatory status will decide which one fits a given application.

FAQ

Does this mean allulose is an appetite suppressant?

In mice, yes under the conditions tested. D-allulose reduced sugar intake and extended satiety. It did not make the solution less appealing. Human trials are still needed.

Is FGF21 the only mechanism?

The study identifies FGF21 induction as the key effect for these rare sugars. It does not rule out other pathways, but the FGF21 signal is the one the authors measured.

Should I put allulose in a product with sugar?

That depends on your goal. The mixing experiment shows that adding these rare sugars to a sucrose solution lowers total intake and preference in mice. If that translates, it gives you a formulation strategy, not just a swap.

Closing

Rare sugars have moved from passive bulking agents to active metabolic signals. This paper adds a clear mechanism and a behavioral outcome. For formulators, the message is direct: D-allulose, D-tagatose, and D-sorbitol may help cut sugar intake through FGF21, and they can work alongside sucrose, not only in place of it.